Literature DB >> 12730672

Physical and functional interaction between HCV core protein and the different p73 isoforms.

Anna Alisi1, Stefania Giambartolomei, Felicia Cupelli, Paola Merlo, Giulia Fontemaggi, Alessandra Spaziani, Clara Balsano.   

Abstract

Hepatitis C virus (HCV) core protein is a structural viral protein that packages the viral genomic RNA. In addition to this function, HCV core also modulates a number of cellular regulatory functions. In fact, HCV core protein has been found to modulate the expression of the cyclin-dependent inhibitor p21(WAF1/CIP1) and to promote both apoptosis and cell proliferation through its physical interaction with p53. Here, we studied the ability of HCV core to bind the p53-related p73 protein, its isoforms and its deletion mutants. We found that HCV core co-immunoprecipitated with p73 in HepG2 and SAOS-2 cells. Deletion mutational analysis of p73 indicates that the domain involved in HCV core binding is located between amino-acid residues 321-353. We also demonstrate that p73/core interaction results in the nuclear translocation of HCV core protein either in the presence of the p73 alpha or p73 beta tumor-suppressor proteins. In addition, the interaction with HCV core protein prevents p73 alpha, but not p73 beta dependent cell growth arrest in a p53-dependent manner. Our findings demonstrate that HCV core protein may directly influence the various p73 functions, thus playing a role in HCV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730672     DOI: 10.1038/sj.onc.1206333

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 2.  Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.

Authors:  Michael J Bouchard; Sonia Navas-Martin
Journal:  Cancer Lett       Date:  2010-12-18       Impact factor: 8.679

Review 3.  Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.

Authors:  Yujin Hoshida; Bryan C Fuchs; Nabeel Bardeesy; Thomas F Baumert; Raymond T Chung
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

Review 4.  Viral hepatocarcinogenesis.

Authors:  W-L Tsai; R T Chung
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

5.  Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family.

Authors:  Jinxiong Wei; Daniel O'Brien; Anna Vilgelm; Maria B Piazuelo; Pelayo Correa; Mary K Washington; Wael El-Rifai; Richard M Peek; Alexander Zaika
Journal:  Gastroenterology       Date:  2008-01-31       Impact factor: 22.682

6.  Oncogenic potential of hepatitis C virus proteins.

Authors:  Arup Banerjee; Ratna B Ray; Ranjit Ray
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.818

7.  p73-Binding Partners and Their Functional Significance.

Authors:  Toshinori Ozaki; Natsumi Kubo; Akira Nakagawara
Journal:  Int J Proteomics       Date:  2011-01-13

Review 8.  Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.

Authors:  Monica Marra; Ignazio M Sordelli; Angela Lombardi; Monica Lamberti; Luciano Tarantino; Aldo Giudice; Paola Stiuso; Alberto Abbruzzese; Rossella Sperlongano; Marina Accardo; Massimo Agresti; Michele Caraglia; Pasquale Sperlongano
Journal:  J Transl Med       Date:  2011-10-10       Impact factor: 5.531

9.  Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.

Authors:  Anna Alisi; Mario Arciello; Stefania Petrini; Beatrice Conti; Gabriele Missale; Clara Balsano
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

Review 10.  Hepatitis C virus and hepatocarcinogenesis.

Authors:  Soung Won Jeong; Jae Young Jang; Raymond T Chung
Journal:  Clin Mol Hepatol       Date:  2012-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.